Postantibiotic and physiological effects of tilmicosin, tylosin, and apramycin at subminimal and suprainhibitory concentrations on some swine and bovine respiratory tract pathogens

International Journal of Antimicrobial Agents

Volumn 12, Issue 3, 1999, Pages 229-237

  Diarra, Moussa S ^a,c   Malouin, François ^a,d   Jacques, Mario ^b  

^a UNIVERSITY OF QUEBEC   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c AGRICULTURE AND AGRI FOOD CANADA   (Canada)

^d Microcide Pharmaceuticals Inc   (United States)

Author keywords

Apramycin; Postantibiotic effect; Sub MIC; Tilmicosin; Tylosin

Indexed keywords

APRAMYCIN; TILMICOSIN; TYLOSIN;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANTIMICROBIAL ACTIVITY; ARTICLE; BORDETELLA BRONCHISEPTICA; CATTLE; CONTROLLED STUDY; MANNHEIMIA HAEMOLYTICA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PASTEURELLA MULTOCIDA; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; SWINE; VETERINARY MEDICINE;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; GRAM-NEGATIVE BACTERIA; HEMOLYSIS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; NEBRAMYCIN; RESPIRATORY SYSTEM; SWINE; TYLOSIN;

EID: 0032769785     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00069-2     Document Type: Article

References (25)

1. Minguez F, Ramos C, Loscos A, Chiu ML, Pietro J. In vitro killing kinetics and postantibiotic effect of josamyn and other macrolides on several bacteria. Chemotherapy 1993;39:163-8.
2. Craig WA, Gudmundsson S. Postantibiotic effect. In: Lorian V, editor. Antibiotics in Laboratory Medicine, 3th edn. New York: Williams and Wilkins, 1991.
3. Leman AD, Straw BE, Mengeling WL, D'Allaire S, Taylor DJ, editors. Diseases of Swine, 7th edn. Ames, IA: Iowa State University Press, 1992.
4. Adlam C, Rutter JM, editors. Pasteurella and Pasteurellosis. London: Academic Press, 1989.
5. Chanter N. Molecular aspects of the virulence of Pasteurella multocida. Can J Vet Res 1990;54:S45-7.
6. Frey J. Virulence in Actinobacillus pleuropneumoniae and RTX toxins. Trends Microbiol 1995;3:257-61.
7. Haesebrouck F, Chiers K, Van Overbeke I, Ducatelle R. Actinobacillus pleuropneumoniae infections in pigs: the role of virulence factors in pathogenesis and protection. Vet Microbiol 1997;58:239-49.
8. Paradis SE, Dubreuil D, Rioux S, Gottschalk M, Jacques M. High-molecular-mass lipopolysaccharides are involved in Actinobacillus pleuropneumoniae adherence to porcine respiratory tract cells. Infect Immun 1994;62:3311-9.
9. Confer AW, Clinkenbeard KD, Murphy GL. Pathogenesis and virulence of Pasteurella haemolytica in cattle: an analysis of current knowledge and future approaches. In: Donachie W, et al., editors. Haemophilus, Actinobacillus, and Pasteurella. New York: Plenum, 1995.
10. Lorian V, Gemmell CG. Effects of low antibiotic concentrations on bacteria: effects on ultrastructure, virulence, and susceptibility to immunodefenses. In: Lorian V, editor. Antibiotics in Laboratory Medicine, 3rd edn. Baltimore, MA: Williams and Wilkins, 1991.
11. Shryock TR, Mortensen JE, Baumholtz M. The effects of macrolides on the expression of bacterial virulence mechanisms. J Antimicrob Chemother 1998;41:505-12.
12. Woods GL, Washington JA. Antibacterial susceptibility test: dilution and disk diffusion methods. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology, 6th edn. Washington, DC: American Society for Microbiology Press, 1995.
13. Rescott DL, Nix DE, Holden P, Schentag JJ. Comparison of two methods of determining in vitro postantibiotic effects of three antibiotics on Escherichia coli. Antimicrob Agents Chemother 1988;32:450-3.
14. Jacques M, Foiry B. Electron microscopic visualization of capsular material of Pasteurella multocida types A and D labeled with polycationic ferritin. J Bacteriol 1987;169:3470-2.
15. Frey J, Nicolet J. Hemolysin patterns of Actinobacillus pleuropneumoniae. J Clin Microbiol 1990;28:232-6.
16. Bryskier A, Agouridas C, Gase JC. Classification of macrolide antibiotics. In: Bryskier A, Butzler JP, Neu HC, Tulkens PM, editors. Macrolides: Chemistry, Pharmacology and Clinical Use. Paris: Arnette-Blackwell, 1993.
17. Debono M, Willard KE, Kirst HA, Wind JA, Crouse GD, Tao EV, et al. Synthesis and antimicrobial evaluation of 20-deoxo20-(2,5,-dimethylpiperidin-1-y1)desmicosin (tilmicosin, EL-870) related cyclic amino derivatives. J Antibiot 1989;42:1253-76.
18. Raponi G, Keller N, Overbeck BP, Rosenberg-Arsak M, Van Kessel KPM, Verhoef J. Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface. Antimicrob Agents Chemother 1990;34:332-6.
19. Lorian V. Medical relevance of low concentrations of antibiotics. Antimicrob Agents Chemother 1993;31:137-48.
20. Jacques M, Lebrun A, Foiry B, Dargis M, Malouin F. Effects of antibiotics on the growth and morphology of Pasteurella multocida. J Gen Microbiol 1991;137:2663-8.
21. Feinman SE. Antibiotic in animal feed: drug resistance revisited. ASM News 1998;64:24-30.
22. Isaksson B, Lennart N, Rolf M, Lars S. Postantibiotic effect of aminiglycosides on Gram-negative bacteria evaluated by a new method. J Antimicrob Chemother 1988;22:23-33.
23. Odenholt-Tornqvist I, Löwdin E, Cars O. Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens. Antimicrob Agents Chemother 1995;39:221-6.
24. Löwdin E, Inga O, Bengtsson S, Cars O. A new method to determine postantibiotic effect and effects of subinhibitory antibiotic concentrations. Antimicrob Agents Chemother 1993;37:2200-5.
25. Odenholt-Tornqvist I, Löwdin E, Cars O. Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin. Antimicrob Agents Chemother 1992;36:1852-8.